Skip to Content

61 Results Found

  • Review
  • Open Access
24 Citations
7,003 Views
19 Pages

Does DNA Methylation Matter in FSHD?

  • Valentina Salsi,
  • Frédérique Magdinier and
  • Rossella Tupler

28 February 2020

Facioscapulohumeral muscular dystrophy (FSHD) has been associated with the genetic and epigenetic molecular features of the CpG-rich D4Z4 repeat tandem array at 4q35. Reduced DNA methylation of D4Z4 repeats is considered part of the FSHD mechanism an...

(This article belongs to the Special Issue DNA Methylation in Health and Diseases)
  • Review
  • Open Access
29 Citations
8,630 Views
20 Pages

Therapeutic Strategies Targeting DUX4 in FSHD

  • Laura Le Gall,
  • Eva Sidlauskaite,
  • Virginie Mariot and
  • Julie Dumonceaux

7 September 2020

Facioscapulohumeral muscular dystrophy (FSHD) is a common muscle dystrophy typically affecting patients within their second decade. Patients initially exhibit asymmetric facial and humeral muscle damage, followed by lower body muscle involvement. FSH...

(This article belongs to the Special Issue Innovative Therapies in Neuromuscular Diseases)
  • Review
  • Open Access
14 Citations
8,153 Views
19 Pages

Facioscapulohumeral muscular dystrophy (FSHD) is arguably one of the most challenging genetic diseases to understand and treat. The disease is caused by epigenetic dysregulation of a macrosatellite repeat, either by contraction of the repeat or by mu...

(This article belongs to the Special Issue Neuromuscular and Neurodegenerative Diseases: Towards Personalized Medicine, Therapeutics and Improved Mechanistic Understanding)
  • Review
  • Open Access
21 Citations
5,774 Views
23 Pages

Update on the Molecular Aspects and Methods Underlying the Complex Architecture of FSHD

  • Valerio Caputo,
  • Domenica Megalizzi,
  • Carlo Fabrizio,
  • Andrea Termine and ,
  • Luca Colantoni,
  • Carlo Caltagirone,
  • Emiliano Giardina,
  • Raffaella Cascella and
  • Claudia Strafella
  • + 4 authors+ 0 author

29 August 2022

Despite the knowledge of the main mechanisms involved in facioscapulohumeral muscular dystrophy (FSHD), the high heterogeneity and variable penetrance of the disease complicate the diagnosis, characterization and genotype–phenotype correlation...

(This article belongs to the Special Issue Cellular and Molecular Mechanisms in Neuromuscular Diseases: From Basic Research to Clinical Approach)
  • Review
  • Open Access
15 Citations
7,412 Views
12 Pages

DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation

  • Eva Sidlauskaite,
  • Laura Le Gall,
  • Virginie Mariot and
  • Julie Dumonceaux

Facioscapulohumeral dystrophy (FSHD) is the most frequent muscular disease in adults. FSHD is characterized by a weakness and atrophy of a specific set of muscles located in the face, the shoulder, and the upper arms. FSHD patients may present differ...

(This article belongs to the Special Issue Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function)
  • Article
  • Open Access
17 Citations
4,853 Views
10 Pages

Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?

  • Romains Joubert,
  • Virginie Mariot,
  • Marine Charpentier,
  • Jean Paul Concordet and
  • Julie Dumonceaux

23 December 2020

Facioscapulohumeral dystrophy (FSHD, OMIM: 158900, 158901) is the most common dystrophy in adults and so far, there is no treatment. Different loci of the disease have been characterized and they all lead to the aberrant expression of the DUX4 protei...

(This article belongs to the Special Issue Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function)
  • Article
  • Open Access
3 Citations
3,640 Views
15 Pages

Systemic Pharmacotherapeutic Treatment of the ACTA1-MCM/FLExDUX4 Preclinical Mouse Model of FSHD

  • Ngoc Lu-Nguyen,
  • Stuart Snowden,
  • Linda Popplewell and
  • Alberto Malerba

Aberrant expression of the double homeobox 4 (DUX4) gene in skeletal muscle predominantly drives the pathogenesis of facioscapulohumeral muscular dystrophy (FSHD). We recently demonstrated that berberine, an herbal extract known for its ability to st...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
61 Citations
12,658 Views
25 Pages

DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy

  • Emanuele Mocciaro,
  • Valeria Runfola,
  • Paola Ghezzi,
  • Maria Pannese and
  • Davide Gabellini

26 November 2021

In the last decade, the sequence-specific transcription factor double homeobox 4 (DUX4) has gone from being an obscure entity to being a key factor in important physiological and pathological processes. We now know that expression of DUX4 is highly r...

(This article belongs to the Special Issue Muscle Homeostasis and Regeneration: From Molecular Mechanisms to Therapeutic Opportunities 2021)
  • Article
  • Open Access
20 Citations
7,662 Views
12 Pages

Culture Conditions Affect Expression of DUX4 in FSHD Myoblasts

  • Sachchida Nand Pandey,
  • Hunain Khawaja and
  • Yi-Wen Chen

8 May 2015

Facioscapulohumeral muscular dystrophy (FSHD) is believed to be caused by aberrant expression of double homeobox 4 (DUX4) due to epigenetic changes of the D4Z4 region at chromosome 4q35. Detecting DUX4 is challenging due to its stochastic expression...

(This article belongs to the Special Issue Towards Understanding the Mechanisms and Curing Of Muscular Dystrophy Diseases)
  • Article
  • Open Access
16 Citations
4,298 Views
14 Pages

D4Z4 Methylation Levels Combined with a Machine Learning Pipeline Highlight Single CpG Sites as Discriminating Biomarkers for FSHD Patients

  • Valerio Caputo,
  • Domenica Megalizzi,
  • Carlo Fabrizio,
  • Andrea Termine and ,
  • Luca Colantoni,
  • Cristina Bax,
  • Juliette Gimenez,
  • Mauro Monforte,
  • Giorgio Tasca and
  • Claudia Strafella
  • + 9 authors+ 4 authors

18 December 2022

The study describes a protocol for methylation analysis integrated with Machine Learning (ML) algorithms developed to classify Facio-Scapulo-Humeral Dystrophy (FSHD) subjects. The DNA methylation levels of two D4Z4 regions (DR1 and DUX4-PAS) were ass...

  • Article
  • Open Access
4 Citations
5,131 Views
22 Pages

Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells

  • Christopher D. Sarsons,
  • Dean Gilham,
  • Laura M. Tsujikawa,
  • Sylwia Wasiak and ,
  • Li Fu,
  • Brooke D. Rakai,
  • Stephanie C. Stotz,
  • Agostina Carestia,
  • Michael Sweeney and
  • Ewelina Kulikowski
  • + 5 authors+ 0 author

30 September 2023

Facioscapulohumeral dystrophy (FSHD) is a muscle disease caused by inappropriate expression of the double homeobox 4 (DUX4) gene in skeletal muscle, and its downstream activation of pro-apoptotic transcriptional programs. Inhibitors of DUX4 expressio...

(This article belongs to the Topic Research in Pharmacological Therapies)
  • Article
  • Open Access
15 Citations
4,432 Views
18 Pages

Silencing the expression of the double homeobox 4 (DUX4) gene offers great potential for the treatment of facioscapulohumeral muscular dystrophy (FSHD). Several research groups have recently reported promising results using systemic antisense therapy...

(This article belongs to the Special Issue Muscular Dystrophies: Pathophysiology and Therapy)
  • Review
  • Open Access
4 Citations
2,919 Views
15 Pages

Deciphering the Complexity of FSHD: A Multimodal Approach as a Model for Rare Disorders

  • Domenica Megalizzi,
  • Giulia Trastulli,
  • Luca Colantoni,
  • Emma Proietti Piorgo and ,
  • Guido Primiano,
  • Cristina Sancricca,
  • Carlo Caltagirone,
  • Raffaella Cascella,
  • Claudia Strafella and
  • Emiliano Giardina
  • + 5 authors+ 0 author

11 October 2024

Rare diseases are heterogeneous diseases characterized by various symptoms and signs. Due to the low prevalence of such conditions (less than 1 in 2000 people), medical expertise is limited, knowledge is poor and patients’ care provided by medi...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
6 Citations
4,252 Views
10 Pages

Type 1 FSHD with 6–10 Repeated Units: Factors Underlying Severity in Index Cases and Disease Penetrance in Their Relatives Attention

  • Emmanuelle Salort-Campana,
  • Farzad Fatehi,
  • Sadia Beloribi-Djefaflia,
  • Stéphane Roche and ,
  • Karine Nguyen,
  • Rafaelle Bernard,
  • Pascal Cintas,
  • Guilhem Solé,
  • Françoise Bouhour and
  • Shahram Attarian
  • + 11 authors+ 6 authors

Molecular defects in type 1 facioscapulohumeral muscular dystrophy (FSHD) are caused by a heterozygous contraction of the D4Z4 repeat array from 1 to 10 repeat units (RUs) on 4q35. This study compared (1) the phenotype and severity of FSHD1 between p...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
18 Citations
3,777 Views
17 Pages

The true prevalence of facioscapulohumeral muscular dystrophy (FSHD) is unknown due to difficulties with accurate clinical evaluation and the complexities of current genetic diagnostics. Interestingly, all forms of FSHD are linked to epigenetic chang...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
9 Citations
3,790 Views
13 Pages

FSHD1 Diagnosis in a Russian Population Using a qPCR-Based Approach

  • Nikolay Vladimirovich Zernov,
  • Anna Alekseevna Guskova and
  • Mikhail Yurevich Skoblov

Facioscapulohumeral dystrophy (FSHD) is an autosomal dominant myodystrophy. Approximately 95% of cases of FSHD are caused by partial deletion of the D4Z4 macrosatellite tandem repeats on chromosome 4q35. The existing FSHD1 diagnostic methods are labo...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
2 Citations
5,523 Views
15 Pages

Orofacial Muscle Weakening in Facioscapulohumeral Muscular Dystrophy (FSHD) Patients

  • Dimitrios Konstantonis,
  • Kyriaki Kekou,
  • Petros Papaefthymiou,
  • Heleni Vastardis and ,
  • Nikoleta Konstantoni,
  • Maria Athanasiou,
  • Maria Svingou,
  • Anastasia Margariti and
  • Angeliki Panousopoulou
  • + 4 authors+ 0 author

11 January 2022

Background: Facioscapulohumeral muscular dystrophy is the third most commonly found type of muscular dystrophy. The aim of this study was to correlate the D4Z4 repeat array fragment size to the orofacial muscle weakening exhibited in a group of patie...

  • Review
  • Open Access
594 Views
25 Pages

11 September 2026

Facioscapulohumeral muscular dystrophy (FSHD) is a genetically and epigenetically complex autosomal dominant myopathy that presents formidable challenges to molecular diagnosis and reproductive intervention. The disease is caused by aberrant derepres...

(This article belongs to the Special Issue Genetics of Neuromuscular Disorders)
  • Article
  • Open Access
60 Citations
13,142 Views
21 Pages

Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)

  • Eugénie Ansseau,
  • Céline Vanderplanck,
  • Armelle Wauters,
  • Scott Q. Harper and ,
  • Frédérique Coppée and
  • Alexandra Belayew
  • + 1 author+ 0 author

3 March 2017

FacioScapuloHumeral muscular Dystrophy (FSHD) is one of the most prevalent hereditary myopathies and is generally characterized by progressive muscle atrophy affecting the face, scapular fixators; upper arms and distal lower legs. The FSHD locus maps...

(This article belongs to the Special Issue Therapeutic Alternative Splicing: Mechanisms and Applications)
  • Brief Report
  • Open Access
5 Citations
3,294 Views
8 Pages

Evaluation of Optical Genome Mapping in Clinical Genetic Testing of Facioscapulohumeral Muscular Dystrophy

  • Anja Kovanda,
  • Luca Lovrečić,
  • Gorazd Rudolf,
  • Ivana Babic Bozovic and ,
  • Helena Jaklič,
  • Lea Leonardis and
  • Borut Peterlin
  • + 2 authors+ 0 author

30 November 2023

Facioscapulohumeral muscular dystrophy (FSHD) is the third most common hereditary muscular dystrophy, caused by the contraction of the D4Z4 repeats on the permissive 4qA haplotype on chromosome 4, resulting in the faulty expression of the DUX4 gene....

(This article belongs to the Special Issue Advances of Optical Genome Mapping in Human Genetics)
  • Article
  • Open Access
7 Citations
4,515 Views
20 Pages

A Systemically Administered Unconjugated Antisense Oligonucleotide Targeting DUX4 Improves Muscular Injury and Motor Function in FSHD Model Mice

  • Tetsuhiro Kakimoto,
  • Akira Ogasawara,
  • Kiyoshi Ishikawa,
  • Takashi Kurita and ,
  • Kumiko Yoshida,
  • Shuichi Harada,
  • Taeko Nonaka,
  • Yoshimi Inoue,
  • Keiko Uchida and
  • Hajime Aihara
  • + 9 authors+ 4 authors

Facioscapulohumeral muscular dystrophy (FSHD), one of the most common muscular dystrophies, is caused by an abnormal expression of the DUX4 gene in skeletal muscles, resulting in muscle weakness. In this study, we investigated MT-DUX4-ASO, a novel ga...

(This article belongs to the Special Issue Diagnosis, Pathogenesis and Treatment of Muscular Dystrophy)
  • Review
  • Open Access
27 Citations
11,219 Views
17 Pages

21 October 2020

Facioscapulohumeral muscular dystrophy (FSHD)—the worldwide third most common inherited muscular dystrophy caused by the heterozygous contraction of a 3.3 kb tandem repeat (D4Z4) on a chromosome with a 4q35 haplotype—is a progressive gene...

(This article belongs to the Special Issue Genetic Basis and Epidemiology of Myopathies)
  • Article
  • Open Access
26 Citations
6,516 Views
18 Pages

Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy

  • Adam J. Bittel,
  • Sen Chandra Sreetama,
  • Daniel C. Bittel,
  • Adam Horn and ,
  • James S. Novak,
  • Toshifumi Yokota,
  • Aiping Zhang,
  • Rika Maruyama,
  • Kenji Rowel Q. Lim and
  • Yi-Wen Chen
  • + 6 authors+ 1 author

Deficits in plasma membrane repair have been identified in dysferlinopathy and Duchenne Muscular Dystrophy, and contribute to progressive myopathy. Although Facioscapulohumeral Muscular Dystrophy (FSHD) shares clinicopathological features with these...

(This article belongs to the Special Issue Muscle Atrophy: Discovery of Mechanisms and Potential Therapies)
  • Article
  • Open Access
21 Citations
4,548 Views
14 Pages

Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges

  • Stephanie Efthymiou,
  • Richard J. L. F. Lemmers,
  • Venugopalan Y. Vishnu,
  • Natalia Dominik and ,
  • Benedetta Perrone,
  • Stefano Facchini,
  • Elisa Vegezzi,
  • Sabrina Ravaglia,
  • Lindsay Wilson and
  • Enrico Bugiardini
  • + 16 authors+ 11 authors

24 October 2023

Facioscapulohumeral muscular dystrophy (FSHD) is the second most common muscular dystrophy in adults, and it is associated with local D4Z4 chromatin relaxation, mostly via the contraction of the D4Z4 macrosatellite repeat array on chromosome 4q35. In...

(This article belongs to the Section Molecular Genetics)
  • Article
  • Open Access
35 Citations
4,755 Views
17 Pages

Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy

  • Victor Corasolla Carregari,
  • Mauro Monforte,
  • Giuseppe Di Maio,
  • Luisa Pieroni and ,
  • Andrea Urbani,
  • Enzo Ricci and
  • Giorgio Tasca
  • + 2 authors+ 0 author

30 December 2020

Facioscapulohumeral muscular dystrophy (FSHD) is caused by a complex epigenetic mechanism finally leading to the misexpression of DUX4 in skeletal muscle. Detecting DUX4 and quantifying disease progression in FSHD is extremely challenging, thus incre...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
4 Citations
2,597 Views
17 Pages

Facioscapulohumeral muscular dystrophy (FSHD) is caused by the aberrant expression of the double homeobox 4 (DUX4) gene. In this study, an analysis of human FSHD muscle biopsies revealed differential expressions of six m6A regulators, including write...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
22 Citations
4,917 Views
18 Pages

Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies

  • Ana Nikolic,
  • Takako I Jones,
  • Monica Govi,
  • Fabiano Mele and ,
  • Louise Maranda,
  • Francesco Sera,
  • Giulia Ricci,
  • Lucia Ruggiero,
  • Liliana Vercelli and
  • Rossella Tupler
  • + 30 authors+ 25 authors

Facioscapulohumeral muscular dystrophy (FSHD) is characterized by incomplete penetrance and intra-familial clinical variability. The disease has been associated with the genetic and epigenetic features of the D4Z4 repetitive elements at 4q35. Recentl...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
23 Citations
6,175 Views
22 Pages

Multi-Omics Identifies Circulating miRNA and Protein Biomarkers for Facioscapulohumeral Dystrophy

  • Christopher R. Heier,
  • Aiping Zhang,
  • Nhu Y Nguyen,
  • Christopher B. Tully and ,
  • Aswini Panigrahi,
  • Heather Gordish-Dressman,
  • Sachchida Nand Pandey,
  • Michela Guglieri,
  • Monique M. Ryan and
  • Cooperative International Neuromuscular Research Group (CINRG) Investigators
  • + 17 authors+ 12 authors

19 November 2020

The development of therapeutics for muscle diseases such as facioscapulohumeral dystrophy (FSHD) is impeded by a lack of objective, minimally invasive biomarkers. Here we identify circulating miRNAs and proteins that are dysregulated in early-onset F...

(This article belongs to the Special Issue Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function)
  • Review
  • Open Access
31 Citations
14,470 Views
24 Pages

Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials

  • Mehdi Ghasemi,
  • Charles P. Emerson and
  • Lawrence J. Hayward

16 February 2022

Facioscapulohumeral muscular dystrophy (FSHD) is a debilitating muscular dystrophy with a variable age of onset, severity, and progression. While there is still no cure for this disease, progress towards FSHD therapies has accelerated since the under...

(This article belongs to the Section Cellular Neuroscience)
  • Review
  • Open Access
11 Citations
5,876 Views
23 Pages

21 August 2024

Facioscapulohumeral muscular dystrophy (FSHD) is an inherited myopathy, characterized by progressive and asymmetric muscle atrophy, primarily affecting muscles of the face, shoulder girdle, and upper arms before affecting muscles of the lower extremi...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
3 Citations
3,093 Views
11 Pages

Artificial Intelligence for Evaluation of Retinal Vasculopathy in Facioscapulohumeral Dystrophy Using OCT Angiography: A Case Series

  • Martina Maceroni,
  • Mauro Monforte,
  • Rossella Cariola,
  • Benedetto Falsini and ,
  • Stanislao Rizzo,
  • Maria Cristina Savastano,
  • Francesco Martelli,
  • Enzo Ricci,
  • Sara Bortolani and
  • Angelo Maria Minnella
  • + 6 authors+ 1 author

Facioscapulohumeral muscular dystrophy (FSHD) is a slowly progressive muscular dystrophy with a wide range of manifestations including retinal vasculopathy. This study aimed to analyse retinal vascular involvement in FSHD patients using fundus photog...

(This article belongs to the Special Issue Artificial Intelligence in Eye Disease – Volume 2)
  • Review
  • Open Access
3 Citations
5,934 Views
16 Pages

State-of-the-Art and Future Challenges for Nutritional Interventions in Facioscapulohumeral Dystrophy: A Narrative Review

  • Venere Quintiero,
  • Oscar Crisafulli,
  • Daniele Diotti,
  • Rossella Tupler and ,
  • Massimo Negro,
  • Emanuela Lavaselli and
  • Giuseppe D’Antona
  • + 2 authors+ 0 author

17 March 2025

Facioscapulohumeral dystrophy (FSHD), the second most common inherited muscular dystrophy in adulthood, is characterized by progressive muscle loss, accompanied by an increase in fat mass. Beyond these alterations in body composition, which contribut...

(This article belongs to the Section Clinical Nutrition)
  • Article
  • Open Access
2 Citations
3,467 Views
23 Pages

The DUX4–HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected

  • Thuy-Hang Nguyen,
  • Maelle Limpens,
  • Sihame Bouhmidi,
  • Lise Paprzycki and ,
  • Alexandre Legrand,
  • Anne-Emilie Declèves,
  • Philipp Heher,
  • Alexandra Belayew,
  • Christopher R. S. Banerji and
  • Alexandra Tassin
  • + 6 authors+ 1 author

FacioScapuloHumeral muscular Dystrophy (FSHD) is one of the most prevalent inherited muscle disorders and is linked to the inappropriate expression of the DUX4 transcription factor in skeletal muscles. The deregulated molecular network causing FSHD m...

(This article belongs to the Special Issue Molecular Insights into Muscular Dystrophy)
  • Article
  • Open Access
2 Citations
4,599 Views
15 Pages

8 September 2024

There is no general consensus on evaluating disease progression in facioscapulohumeral muscular dystrophy (FSHD). Recently, shear wave elastography (SWE) has been proposed as a noninvasive diagnostic tool to assess muscle stiffness in vivo. Therefore...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Article
  • Open Access
10 Citations
2,508 Views
11 Pages

Maximal Oxygen Consumption Is Negatively Associated with Fat Mass in Facioscapulohumeral Dystrophy

  • Oscar Crisafulli,
  • Luca Grattarola,
  • Giorgio Bottoni,
  • Jessica Lacetera and ,
  • Emanuela Lavaselli,
  • Matteo Beretta-Piccoli,
  • Rossella Tupler,
  • Emiliano Soldini and
  • Giuseppe D’Antona
  • + 4 authors+ 0 author

Facioscapulohumeral dystrophy (FSHD) leads to progressive changes in body composition such as loss of muscle mass and increase in adiposity. In healthy subjects, anthropometric parameters are associated with the maximum volume of oxygen consumed per...

(This article belongs to the Section Health Care Sciences)
  • Article
  • Open Access
617 Views
31 Pages

Sphingolipid Remodeling and Extracellular Vesicle Signatures Reflect Disease Severity in Facioscapulohumeral Dystrophy Driven by Mitochondrial Dysfunction and Endoplasmic Reticulum Stress

  • Manuela Moriggi,
  • Lucia Ruggiero,
  • Enrica Torretta,
  • Dario Zoppi and ,
  • Beatrice Arosio,
  • Chiara Fiorillo,
  • Vincenzo Nigro,
  • Daniele Capitanio and
  • Cecilia Gelfi
  • + 4 authors+ 0 author

14 September 2026

Background: Facioscapulohumeral muscular dystrophy (FSHD) is a progressive and heterogeneous disorder lacking reliable circulating biomarkers for disease monitoring and therapeutic response. We hypothesized that metabolic dysregulation, lipotoxicity,...

  • Article
  • Open Access
15 Citations
3,901 Views
12 Pages

Persistent Fibroadipogenic Progenitor Expansion Following Transient DUX4 Expression Provokes a Profibrotic State in a Mouse Model for FSHD

  • Darko Bosnakovski,
  • David Oyler,
  • Ana Mitanoska,
  • Madison Douglas and ,
  • Elizabeth T. Ener,
  • Ahmed S. Shams and
  • Michael Kyba
  • + 2 authors+ 0 author

11 February 2022

FSHD is caused by loss of silencing of the DUX4 gene, but the DUX4 protein has not yet been directly detected immunohistologically in affected muscle, raising the possibility that DUX4 expression may occur at time points prior to obtaining adult biop...

(This article belongs to the Special Issue Myogenesis and Muscular Disorders)
  • Interesting Images
  • Open Access
3 Citations
1,848 Views
4 Pages

Morpho-Functional Macular Assessment in a Case of Facioscapulohumeral Muscular Dystrophy: Photoreceptor Degeneration as Possible Cause for Reduced Visual Acuity over Three Years of Follow-Up

  • Mariacristina Parravano,
  • Eliana Costanzo,
  • Lucilla Barbano,
  • Pasquale Viggiano and ,
  • Daniele De Geronimo,
  • Giulio Antonelli,
  • Vincenzo Parisi,
  • Monica Varano and
  • Lucia Ziccardi
  • + 4 authors+ 0 author

28 November 2022

Background: Autosomal-dominant facioscapulohumeral muscular dystrophy (FSHD) is a muscular dystrophy with associated retinal abnormalities such as retinal vessel tortuosity, focal retinal pigment epithelium defect and large telangiectasia vessels. Me...

(This article belongs to the Special Issue Structure-Function Relationship in Retinal Diseases)
  • Article
  • Open Access
6 Citations
2,953 Views
20 Pages

Molecular and Phenotypic Changes in FLExDUX4 Mice

  • Kelly Murphy,
  • Aiping Zhang,
  • Adam J. Bittel and
  • Yi-Wen Chen

25 June 2023

Facioscapulohumeral muscular dystrophy (FSHD) is caused by the aberrant expression of the double homeobox 4 (DUX4) gene. The FLExDUX4 mouse model carries an inverted human DUX4 transgene which has leaky DUX4 transgene expression at a very low level....

(This article belongs to the Special Issue Neuromuscular and Neurodegenerative Diseases: Towards Personalized Medicine, Therapeutics and Improved Mechanistic Understanding)
  • Article
  • Open Access
2 Citations
3,233 Views
19 Pages

Molecular, Histological, and Functional Changes in Acta1-MCM;FLExDUX4/+ Mice

  • Solene Sohn,
  • Sophie Reid,
  • Maximilien Bowen,
  • Emilio Corbex and ,
  • Laura Le Gall,
  • Eva Sidlauskaite,
  • Christophe Hourde,
  • Baptiste Morel,
  • Virginie Mariot and
  • Julie Dumonceaux
  • + 5 authors+ 0 author

23 October 2024

DUX4 is the major gene responsible for facioscapulohumeral dystrophy (FSHD). Several mouse models expressing DUX4 have been developed, the most commonly used by academic laboratories being ACTA1-MCM/FLExDUX4. In this study, molecular and histological...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Communication
  • Open Access
2,253 Views
12 Pages

Dux Is Dispensable for Skeletal Muscle Regeneration: A Study Inspired by a “Red Flagged” Publication and Editorial Oversight

  • Kenric Chen,
  • Erdong Wei,
  • Ana Mitanoska,
  • Micah D. Gearhart and ,
  • Michael Kyba and
  • Darko Bosnakovski
  • + 1 author+ 0 author

12 May 2025

Double homeobox (DUX) genes are key embryonic regulators that are silenced after the early cleavage stages of embryogenesis. Aberrant expression of DUX4 in skeletal muscle is linked to facioscapulohumeral muscular dystrophy (FSHD). A recent study rep...

  • Review
  • Open Access
5 Citations
7,176 Views
13 Pages

12 September 2024

Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant genetic disease, which is caused by the mistaken expression of double homeobox protein 4 protein 4 (DUX4) in skeletal muscle. Patients with FSHD are usually accompanied by degener...

  • Review
  • Open Access
17 Citations
7,754 Views
23 Pages

Facioscapulohumeral muscular dystrophy (FSHD) represents the third most common form of muscular dystrophy and is characterized by muscle weakness and atrophy. FSHD is caused by the altered expression of the transcription factor double homeobox 4 (DUX...

(This article belongs to the Special Issue Molecular Advances of Muscular Dystrophy)
  • Article
  • Open Access
13 Citations
5,949 Views
37 Pages

Nutritional Status of Patients with Facioscapulohumeral Muscular Dystrophy

  • Sedda Amzali,
  • Vinicius Dias Wilson,
  • Sébastien Bommart,
  • Marie-Christine Picot and ,
  • Simon Galas,
  • Jacques Mercier,
  • Patrick Poucheret,
  • Jean-Paul Cristol,
  • Sandrine Arbogast and
  • Dalila Laoudj-Chenivesse
  • + 5 authors+ 0 author

30 March 2023

In patients with facioscapulohumeral muscular dystrophy (FSHD), a rare genetic neuromuscular disease, reduced physical performance is associated with lower blood levels of vitamin C, zinc, selenium, and increased oxidative stress markers. Supplementa...

(This article belongs to the Special Issue Nutrition Care for Rare Diseases Patients)
  • Article
  • Open Access
12 Citations
3,409 Views
32 Pages

Muscle Proteome Analysis of Facioscapulohumeral Dystrophy Patients Reveals a Metabolic Rewiring Promoting Oxidative/Reductive Stress Contributing to the Loss of Muscle Function

  • Manuela Moriggi,
  • Lucia Ruggiero,
  • Enrica Torretta,
  • Dario Zoppi and ,
  • Beatrice Arosio,
  • Evelyn Ferri,
  • Alessandra Castegna,
  • Chiara Fiorillo,
  • Cecilia Gelfi and
  • Daniele Capitanio
  • + 5 authors+ 0 author

16 November 2024

Facioscapulohumeral muscular dystrophy (FSHD) is caused by the epigenetic de-repression of the double homeobox 4 (DUX4) gene, leading to asymmetric muscle weakness and atrophy that begins in the facial and scapular muscles and progresses to the lower...

  • Review
  • Open Access
61 Citations
11,743 Views
17 Pages

DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy

  • Kenji Rowel Q. Lim,
  • Quynh Nguyen and
  • Toshifumi Yokota

Facioscapulohumeral muscular dystrophy (FSHD) is a disabling inherited muscular disorder characterized by asymmetric, progressive muscle weakness and degeneration. Patients display widely variable disease onset and severity, and sometimes present wit...

(This article belongs to the Special Issue Signalling Pathways in Skeletal Muscle Differentiation, Histogenesis and Repair)
  • Review
  • Open Access
1 Citations
3,066 Views
18 Pages

DUX4 is typically a repressed transcription factor, but its aberrant activation in Facioscapulohumeral Muscular Dystrophy (FSHD) leads to cell death by disrupting muscle homeostasis. This disruption affects crucial processes such as myogenesis, sarco...

(This article belongs to the Section Molecular Biology)
  • Case Report
  • Open Access
5 Citations
985 Views
2 Pages

19 June 2019

The co-existence of facioscapulohumeral muscle dystrophy (FSHD) and myasthenia gravis (MG) is very rare and few cases have been described in the literature. To increase the awareness of the health care providers, we present herein a rare case of MG i...

  • Review
  • Open Access
38 Citations
7,658 Views
20 Pages

Annexins and Membrane Repair Dysfunctions in Muscular Dystrophies

  • Coralie Croissant,
  • Romain Carmeille,
  • Charlotte Brévart and
  • Anthony Bouter

Muscular dystrophies constitute a group of genetic disorders that cause weakness and progressive loss of skeletal muscle mass. Among them, Miyoshi muscular dystrophy 1 (MMD1), limb girdle muscular dystrophy type R2 (LGMDR2/2B), and LGMDR12 (2L) are c...

(This article belongs to the Special Issue Cell Signaling and Omics in Muscular Dystrophies)
  • Feature Paper
  • Review
  • Open Access
34 Citations
6,961 Views
15 Pages

Redox Homeostasis in Muscular Dystrophies

  • Nicola Mosca,
  • Sara Petrillo,
  • Sara Bortolani,
  • Mauro Monforte and ,
  • Enzo Ricci,
  • Fiorella Piemonte and
  • Giorgio Tasca
  • + 2 authors+ 0 author

1 June 2021

In recent years, growing evidence has suggested a prominent role of oxidative stress in the pathophysiology of several early- and adult-onset muscle disorders, although effective antioxidant treatments are still lacking. Oxidative stress causes cell...

(This article belongs to the Special Issue The Role of Skeletal Muscle in Neuromuscular Diseases: From Cellular and Molecular Players to Therapeutic Interventions)

of 2